Russell Investments Group
FENC icon

Russell Investments Group’s Fennec Pharmaceuticals FENC Stock Holding History

Russell Investments Group’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$143K Buy
13,256
+10,394
+363% +$84.9K ﹤0.01% 3309
2026
Q1 		$17.6K Sell
2,862
-62
-2% -$479 ﹤0.01% 3658
2025
Q4 		$22.5K Sell
2,924
-750
-20% -$6.16K ﹤0.01% 3589
2025
Q3 		$34.4K Buy
3,674
+2,698
+276% +$23.4K ﹤0.01% 3421
2025
Q2 		$8.1K Buy
976
+527
+117% +$3.6K ﹤0.01% 3370
2025
Q1 		$2.73K Buy
449
+72
+19% +$462 ﹤0.01% 3468
2024
Q4 		$2.38K Sell
377
-59,440
-99% -$304K ﹤0.01% 3411
2024
Q3 		$299K Buy
59,817
+6,508
+12% +$37.6K ﹤0.01% 2410
2024
Q2 		$326K Buy
53,309
+19,049
+56% +$158K ﹤0.01% 2352
2024
Q1 		$381K Buy
34,260
+34,212
+71,275% +$344K ﹤0.01% 2289
2023
Q4 		$539 Sell
48
-273
-85% -$2.26K ﹤0.01% 3118
2023
Q3 		$2.41K Buy
+321
New +$2.61K ﹤0.01% 3239
2021
Q4 		– Sell
-31,728
Closed -$298K – 3025
2021
Q3 		$298K Sell
31,728
-80,856
-72% -$607K ﹤0.01% 2652
2021
Q2 		$820K Sell
112,584
-83,893
-43% -$560K ﹤0.01% 2399
2021
Q1 		$1.22M Sell
196,477
-21,642
-10% -$163K ﹤0.01% 2161
2020
Q4 		$1.62M Hold
218,119
– – ﹤0.01% 1867
2020
Q3 		$1.32M Buy
+218,119
New +$1.54M ﹤0.01% 1927
2019
Q1 		– Sell
-28,132
Closed -$178K – 2938
2018
Q4 		$178K Buy
+28,132
New +$197K ﹤0.01% 2625

Other funds holding FENC

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Cornerstone Capital Palo Alto, California $1.12B AUM 28.84% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
HFM
Hartford Financial Management Hartford, Connecticut $448M AUM 32.11% 1-Year Est. Return
EC
Eleva Capital Paris, France $343M AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Russell Investments Group's FENC Position: Q2 2026 in Review

Russell Investments Group increased its Fennec Pharmaceuticals (FENC) stake by 363% in Q2 2026, buying an estimated $84.9K and bringing the position to 13,256 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #3309.

Russell Investments Group first reported a position in FENC in Q4 2018 and has held it in 18 quarters since. The position peaked at $1.62M in Q4 2020. 37 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • Russell Investments Group held 13,256 shares of Fennec Pharmaceuticals worth $143K as of Q2 2026.
  • Russell Investments Group bought 10,394 Fennec Pharmaceuticals shares in Q2 2026, an estimated $84.9K.
  • Fennec Pharmaceuticals made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3309 holding.
  • Russell Investments Group first reported a position in Fennec Pharmaceuticals in Q4 2018 and has held it in 18 quarters since.
  • Russell Investments Group's Fennec Pharmaceuticals position peaked at $1.62M in Q4 2020.
  • 37 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.